INSIGHTS OVERHEARD By Mary Kane Monday, May 19, 2014 12:00 AM “Valeant’s hostile takeover pursuit of Allergan, complete with a ‘poison pill’ defense, is playing out like a juicy boardroom soap opera.” mkane@jobson.com